Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Purchase individual online access for 1 year to this journal.
Price: EUR 595.00Impact Factor 2024: 3.4
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease.
The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
Authors: Flanagan, Margaret E. | Cholerton, Brenna | Latimer, Caitlin S. | Hemmy, Laura S. | Edland, Steven D. | Montine, Kathleen S. | White, Lon R. | Montine, Thomas J.
Article Type: Research Article
Abstract: Transactive response binding protein-43 (TDP-43) cytoplasmic neuronal and glial aggregates (pathologic TDP-43) have been described in multiple brain diseases. We describe the associations between neuropathologically confirmed TDP-43 and cognition in two population-based cohorts: the Nun Study (NS) and the Honolulu-Asia Aging Study (HAAS). In the HAAS, there was a significant association between hippocampal sclerosis (HS) and TDP-43 (OR = 11.04, p < 0.0001, 95% CI 3.57–34.13). In the NS, there were significant associations between TDP-43 and HS (OR = 16.44, p > 0.001 95%, CI 7.10–38.00) and Alzheimer’s disease (AD) severity (OR = 1.74, p = 0.009, 95% CI 1.15–2.64). When cognitive scores were added to the model, HS …remained significant but the other variables were not. When HS was removed from the model, the overall model remained significant and the associations between cognitive performance and TDP-43 (OR = 2.11, p = 0.022, 95% CI 1.11–4.02) were significant. In the NS, there was a significant association between cognitive performance and TDP-43 (OR 1.94 p = 0.005, 95% CI 1.22–3.09) (HS remained significant, but AD did not). When HS was removed from the model, only CERAD was significant (OR = 2.43 p < 0.001, 95% CI 1.58–3.74). These results support a consistent association between pathologic TDP-43, HS, and the development of cognitive impairment in two large studies of brain aging, while the relationship between AD pathology and TDP-43 may vary according to cohort-specific features. Show more
Keywords: Alzheimer’s disease, associations, hippocampal sclerosis, TDP43
DOI: 10.3233/JAD-180162
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1549-1558, 2018
Authors: Xie, Yan-Chun | Yao, Zhao-Hui | Yao, Xiao-Li | Pan, Jian-Zhen | Zhang, Shao-Feng | Zhang, Yong | Hu, Ji-Chang
Article Type: Research Article
Abstract: Chronic cerebral hypoperfusion (CCH) affects the aging population and especially patients with neurodegenerative diseases, such as Alzheimer’s disease or Parkinson’s disease. CCH is closely related to the cognitive dysfunction in these diseases. Glucagon-like peptide-2 receptor (GLP2R) mRNA and protein are highly expressed in the gut and in hippocampal neurons. This receptor is involved in the regulation of food intake and the control of energy balance and glucose homeostasis. The present study employed behavioral techniques, electrophysiology, western blotting, immunohistochemistry, quantitative real time polymerase chain reaction (qRT-PCR), and Golgi staining to investigate whether the expression of GLP2R changes after CCH and whether …GLP2R is involved in cognitive impairment caused by CCH. Our findings show that CCH significantly decreased hippocampal GLP2R mRNA and protein levels. GLP2R upregulation could prevent CCH-induced cognitive impairment. It also improved the CCH-induced impairment of long-term potentiation and long-term depression. Additionally, GLP2R modulated after CCH the AKT-mTOR-p70S6K pathway in the hippocampus. Moreover, an upregulation of the GLP2R increased the neurogenesis in the dentate gyrus, neuronal activity, and density of dendritic spines and mushroom spines in hippocampal neurons. Our findings reveal the involvement of GLP2R via a modulation of the AKT-mTOR-p70S6K pathway in the mechanisms underlying CCH-induced impairments of spatial learning and memory. We suggest that the GLP2R and the AKT-mTOR-p70S6K pathway in the hippocampus are promising targets to treat cognition deficits in CCH. Show more
Keywords: Chronic cerebral hypoperfusion, cognitive dysfunction, glucagon-like peptide-2 receptor, neural plasticity
DOI: 10.3233/JAD-180782
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1559-1576, 2018
Authors: Gambogi, Leandro Boson | Guimarães, Henrique Cerqueira | de Souza, Leonardo Cruz | Caramelli, Paulo
Article Type: Research Article
Abstract: Background: The behavioral variant frontotemporal dementia (bvFTD) shares some clinical features with severe mental disorders, such as bipolar affective disorder (BAD), schizophrenia (SCZ), and schizoaffective disorder (SZA), and at least for a small subgroup of patients, these conditions may share similar pathological genetic mutations. Objectives: To investigate the frequency of a past medical history satisfying diagnostic criteria for BAD, SCZ, and SZA in a bvFTD outpatient sample, and to compare the clinical profile of patients with and without a positive history. Methods: Cross-sectional study in which participants were consecutively selected after receiving a diagnosis of probable …bvFTD and had a caregiver interviewed with SCID-I. The sample was categorized into two groups: with (bvFTD+) or without (bvFTD–) prior medical history satisfying diagnostic criteria for BAD/SCZ/SZA. Subjects went through cognitive, functional, and neuropsychiatric evaluations. Results: Overall, 46 bvFTD patients were included; bvFTD+ patients accounted for 36.9% of the sample. The main nosology fulfilling criteria was BAD (76.5%). The groups differed in Neuropsychiatric Inventory scores (p = 0.01), use of antipsychotics (p = 0.01), family history of psychosis (p = 0.01), presence of primitive reflexes (p = 0.04), Frontal Assessment Battery performance (p = 0.01), Ekman’s facial emotion recognition test (p = 0.03), frequency of apathy (p = 0.03), and stereotyped behavior (p = 0.01). All these parameters were more frequent/worse in the bvFTD+ group. Conclusions: A prior medical history compatible with BAD/SCZ/SZA was found in more than 1/3 of this sample of bvFTD patients and was associated with subtle distinctive clinical features. Show more
Keywords: Bipolar disorder, dementia, schizoaffective disorder, schizophrenia
DOI: 10.3233/JAD-180528
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1577-1585, 2018
Authors: Boespflug, Erin L. | Simon, Matthew J. | Leonard, Emmalyn | Grafe, Marjorie | Woltjer, Randall | Silbert, Lisa C. | Kaye, Jeffrey A. | Iliff, Jeffrey J.
Article Type: Research Article
Abstract: Waste clearance from the brain parenchyma occurs along perivascular pathways. Enlargement of the perivascular space (ePVS) is associated with pathologic features of Alzheimer’s disease (AD), although the mechanisms and implications of this dilation are unclear. Fluid exchange along the cerebral vasculature is dependent on the perivascular astrocytic water channel aquaporin-4 (AQP4) and loss of perivascular AQP4 localization is found in AD. We directly measured ePVS in postmortem samples of pathologically characterized tissue from participants who were cognitively intact or had AD or mixed dementia (vascular lesions with AD). We found that both AD and mixed dementia groups had significantly increased …ePVS compared to cognitively intact subjects. In addition, we found increased global AQP4 expression of the AD group over both control and mixed dementia groups and a qualitative reduction in perivascular localization of AQP4 in the AD group. Among these cases, increasing ePVS burden was associated with the presence of tau and amyloid-β pathology. These findings are consistent with the existing evidence of ePVS in AD and provide novel information regarding differences in AD and vascular dementia and the potential role of astroglial pathology in ePVS. Show more
Keywords: Amyloid, aquaporin-4, astrocytes, cerebrovascular disease, glymphatic, perivascular space, virchow-robin space
DOI: 10.3233/JAD-180367
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1587-1597, 2018
Authors: Shea, Yat-Fung | Barker, Warren | Greig-Gusto, Maria T. | Loewenstein, David A. | DeKosky, Steven T. | Duara, Ranjan
Article Type: Research Article
Abstract: Background: The impact of amyloid positron emission tomography (Aβ-PET) in a “real-world” memory disorders clinic remains poorly studied. Objective: We studied the impact of Aβ-PET in diagnosis and management in the memory clinic and factors making the most impact in diagnosis and management. Methods: We studied 102 patients who had presented at a memory disorders clinic (the Wien Center for Alzheimer’s Disease and Memory Disorders, Miami Beach, FL) and had a diagnostic work-up for cognitive complaints, including Aβ-PET scans. Results: Following Aβ-PET, changes were made in diagnosis (37.3%), in specific treatments for Alzheimer’s disease …(26.5%) and in psychiatric treatments (25.5%). The agreement between diagnosis pre-Aβ-PET versus post-Aβ-PET diagnosis was only fair, with a Cohen’s kappa of 0.23 (95% CI 0–0.42). Patients with MRI findings suggestive of AD (medial temporal and/or parietal atrophy) were more frequently amyloid positive than amyloid negative (66.2% versus 33.8%, p = 0.04). Among patients with atypical clinical features for AD, but with MRI findings suggestive of AD, an amyloid negative PET scan had a greater impact than an amyloid positive PET scan on diagnosis (84.2% versus 17.1%, p < 0.001), management (84.2% versus 40%, p < 0.01) and discussion of results and advice on lifestyle (73.7% versus 22.9%, p < 0.001). Conclusions: We conclude that MRI features suggestive of AD predict a positive amyloid PET scan. However, among those with MRI features suggestive of AD but with atypical clinical features of AD, the clinical impact on diagnosis and management is greater for an amyloid negative than an amyloid positive Aβ-PET scans. Show more
Keywords: Alzheimer’s disease, amyloid imaging, diagnosis, management, memory clinic, positron emission tomography
DOI: 10.3233/JAD-180683
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1599-1608, 2018
Authors: Thyrian, Jochen René | Michalowsky, Bernhard | Hertel, Johannes | Wübbeler, Markus | Gräske, Johannes | Holle, Bernhard | Schäfer-Walkmann, Susanne | Wolf-Ostermann, Karin | Hoffmann, Wolfgang
Article Type: Research Article
Abstract: Background: There is no common definition for the Dementia Care Network (DCN). They are heterogeneous and there is no general, longitudinal evidence for the effects of DCN. Objective: We describe changes in utilization of health services by people served by dementia care networks in Germany and factors associated with those changes over time. Methods: Primary data was assessed in 560 people with dementia (PwD) and their caregivers supported by DCN in Germany; sociodemographic and clinical variables, utilization of services; DCN were characterized according to governance. The design: observational study with face-to-face interviews at two time points …over a period of one year. Data was assessed via semi-structured interviews at the participants’ homes. Results: Utilization of health services in this study is consistently higher than reported for the general population and does not significantly change over time. The strongest predictor of utilization of any service after one year was the use of this service at baseline (OR from 3.23 to 44.16). Higher activities of daily functioning increased the chances to utilize specialist physicians (OR = 1.32; 95% -CI: 1.08–1.63) or occupational therapy (OR = 1.24; 95% -CI: 1.02–1.50) significantly. Being a female decreased chances to utilize specialist physicians (OR = 0.57; 95% -CI: 0.37–0.87) and increased the chances to utilize no services (OR = 2.08; 95% -CI: 1.29–3.33). Conclusion: While health care acknowledges the importance and benefits of dementia care networks (i.e., in Germany, the results were considered in new German legislation (SGB XI)), further research is needed to define this kind of service delivery to facilitate comparison as well as promote evidence-based implementation. Show more
Keywords: Care network, dementia, Germany, health services
DOI: 10.3233/JAD-180758
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1609-1617, 2018
Authors: Penninkilampi, Ross | Casey, Anne-Nicole | Singh, Maria Fiatarone | Brodaty, Henry
Article Type: Research Article
Abstract: It has been reported that social engagement may be associated with dementia risk. We searched PubMed, EMBASE, PsycINFO, CINAHL, LILACS, Biomed Central, Scopus, and Web of Science from January 2012 – May 2017, supplemented by extraction from previous reviews. We included cohort and case-control studies examining the association between social engagement or loneliness and dementia risk, pooling data using a random-effects model. Registered: PROSPERO (CRD42017067074). We included 31 cohort and 2 case-control studies comprising 2,370,452 participants. Poor social engagement indices were associated with increased dementia risk, including having a poor social network (RR = 1.59, 95% CI 1.31–1.96; I2 = 0.00%) and poor …social support (RR = 1.28, 95% CI 1.01–1.62; I2 = 55.51%). In long-term studies (≥10 years), good social engagement was modestly protective (RR = 0.88, 95% CI 0.80–0.96; I2 = 0.00%). Loneliness was non-significantly associated with increased risk (RR = 1.38, 95% CI 0.98–1.94; I2 = 45.32). Our findings encourage interventions targeting social isolation and disengagement for dementia prevention. Show more
Keywords: Alzheimer’s disease, dementia, engagement, loneliness, meta-analysis, socialization, social isolation, systematic review
DOI: 10.3233/JAD-180439
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1619-1633, 2018
Authors: Francis, Paul T. | Costello, Helen | Hayes, Gillian M.
Article Type: Research Article
Abstract: Brain banking has a long and distinguished past, contributing greatly to our understanding of human neurological and psychiatric conditions. Brain banks have been operationally diverse, collecting primarily end stage disease, with variable quality clinical data available, yet it is now recognized the most informative brain donations are from those in longitudinally studied cohorts. The Brains for Dementia Research (BDR) cohort and program was for planned brain donation across five UK brain banks and one donation point, with standardized operating procedures, following longitudinal clinical and psychometric assessments for people with no cognitive impairment as well as those with dementia. Lay …representatives with experience of dementia were involved from inception of BDR and 74.5% of all enquiries about participation came through routes that were directly attributable to or influenced by lay representatives. Ten years after inception, this ongoing project has received over 700 brain donations from the recruited cohort of 3,276 potential brain donors. At cohort census for this paper, 72.2% of the living cohort have no cognitive impairment by assessment, whereas only 28.3% of the donated cohort were without cognitive impairment. It is important that brain banks are agile and reflect the changing needs of the research community, given that ‘big data’, readiness cohorts, and GWAS demand large sample numbers of highly characterized individuals to facilitate new approaches and understanding of pathological processes in dementia. Show more
Keywords: Brain donation, cohort, control, dementia, research tissue bank
DOI: 10.3233/JAD-180699
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1635-1644, 2018
Authors: Chen, Ben | Zhong, Xiaomei | Mai, Naikeng | Peng, Qi | Zhang, Min | Chen, Xinru | Wu, Zhangying | Zou, Laiquan | Liang, Wanyuan | Ouyang, Cong | Wu, Yujie | Ning, Yuping
Article Type: Research Article
Abstract: Olfactory identification (OI) deficits have been regarded as an indicator of cognitive impairment in the elderly, but few studies have analyzed the mixed effect of depression on OI. Since depression is common in the elderly and strongly associated with OI, we aimed to explore whether the comorbidity of depression and cognitive impairment may be associated with worse outcomes. In total, 153 elderly patients with depression and 154 normal elderly were recruited. Subjects underwent assessments of depression, cognitive function, and OI. Information on the factors that may affect OI performance was collected (age, sex, smoking history, diabetes, etc.). Correlation analysis showed …that several factors had a significant influence on OI performance in the elderly, including severity of depression, cognitive scores, age, sex, and years of education (p < 0.05). Among the different cognitive domains, OI was positively associated with global cognition, memory, language, executive function, and attention performance (p < 0.05). The multiple linear regression analysis indicated that memory scores, age, HAMD scores, and sex were the most relevant factors to OI scores across all elderly participants. The factorial analysis suggested that elderly with comorbidity of depression and cognitive impairment (memory deficits or language deficits) had worse OI impairment, and there was an interactive effect of depression and memory deficits on OI in elderly people. The present study suggested that the coexistence of depressive symptoms and cognitive impairment was associated with worse OI in the elderly. Studies exploring the association between OI and cognitive function should include an assessment of depression and adjust the interactive effects of depression. Show more
Keywords: Cognition, depression, geriatric, neuropsychology, olfactory
DOI: 10.3233/JAD-180760
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1645-1655, 2018
Authors: Syeda, Tauqeerunnisa | Sanchez-Tapia, Mónica | Pinedo-Vargas, Laura | Granados, Omar | Cuervo-Zanatta, Daniel | Rojas-Santiago, Eleazar | Díaz-Cintra, Sof&a | Torres, Nimbe | Perez-Cruz, Claudia
Article Type: Research Article
Abstract: Recent investigations have demonstrated an important role of gut microbiota (GM) in the pathogenesis of Alzheimer’s disease (AD). GM modulates a host’s health and disease by production of several substances, including lipopolysaccharides (LPS) and short-chain fatty acids (SCFAs), among others. Diet can modify the composition and diversity of GM, and ingestion of a healthy diet has been suggested to lower the risk to develop AD. We have previously shown that bioactive food (BF) ingestion can abate neuroinflammation and oxidative stress and improve cognition in obese rats, effects associated with GM composition. Therefore, BF can impact the gut-brain axis and improved …behavior. In this study, we aim to explore if inclusion of BF in the diet may impact central pathological markers of AD by modulation of the GM. Triple transgenic 3xTg-AD (TG) female mice were fed a combination of dried nopal, soy, chia oil, and turmeric for 7 months. We found that BF ingestion improved cognition and reduced Aβ aggregates and tau hyperphosphorylation. In addition, BF decreased MDA levels, astrocyte and microglial activation, PSD-95, synaptophysin, GluR1 and ARC protein levels in TG mice. Furthermore, TG mice fed BF showed increased levels of pGSK-3β . GM analysis revealed that pro-inflammatory bacteria were more abundant in TG mice compared to wild-type, while BF ingestion was able to restore the GM’s composition, LPS, and propionate levels to control values. Therefore, the neuroprotective effects of BF may be mediated, in part, by modulation of GM and the release of neurotoxic substances that alter brain function. Show more
Keywords: Lipopolysaccharide, microbiota, neuroinflammation, pro-inflammatory bacteria, propionate, sirt1
DOI: 10.3233/JAD-180556
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1657-1682, 2018
Authors: Zanco, Marcos | Plácido, Jessica | Marinho, Valeska | Ferreira, José Vinicius | de Oliveira, Felipe | Monteiro-Junior, Renato | Barca, Maria | Engedal, Knut | Laks, Jerson | Deslandes, Andrea
Article Type: Research Article
Abstract: Background: Spatial navigation is a fundamental cognitive ability that allows an individual to maintain independence by facilitating the safe movement from one place to another. It emerges as one of the first deficits in patients with Alzheimer’s disease (AD). Objective: To compare spatial navigation performance in the healthy elderly and AD patients through use of the Floor Maze Test (FMT)— an easy-to-apply two-dimensional (2D) maze— and determine which cognitive and functional capacities were associated with performance in this task. Methods: The FMT was administered to 24 AD patients and 36 healthy controls. Spatial navigation was evaluated …through the FMT. Functional capacity was evaluated through the Senior Fitness Test battery of tests. Cognitive functions were evaluated through the Mini-Mental State Examination (MMSE), verbal fluency, digit span test, and the Rey Auditory Verbal Learning Test (RAVLT). Results: The group with AD was significantly slower and presented more errors at all stages of the FMT. Planning Time (PT) performance was associated with cardiorespiratory resistance (Step test) and delayed memory according to the RAVLT (R2 = 0.395, p < 0.001). Performance in the Immediate Maze Time (IMT) and Delayed Maze Time (DMT) was associated with global cognitive status (MMSE) (R2 = 0.509) and delayed memory (R2 = 0.540). Conclusion: Patients with AD present significant spatial navigation deficits. Their performance on the FMT is influenced by cardiorespiratory capacity, memory, and global cognitive function. As exercise helps to improve executive function and functional capacity, future intervention studies should be carried out to analyze the possible effects of physical exercise on spatial navigation. Show more
Keywords: Alzheimer’s disease, functional capacity, executive function, spatial navigation
DOI: 10.3233/JAD-180819
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1683-1694, 2018
Authors: Gu, Jianlan | Chen, Feng | Chu, Dandan | Lu, Ying | Iqbal, Khalid | Gong, Cheng-Xin | Liu, Fei
Article Type: Research Article
Abstract: Alternative splicing of tau exon 10 generates tau isoforms with three or four microtubule-binding repeats, 3R-tau or 4R-tau, which are under developmental regulation. Dysregulation of tau exon 10 splicing is sufficient to cause neurodegenerative disorders. The RNA-binding Fox3 (Rbfox3), identified as NeuN, regulates RNA processing. However, whether Rbfox3/NeuN regulates tau exon 10 splicing is unknown. In the present study, we found that the developmental expression of 4R-tau coincided with the expression of Rbfox3 in rat brains. Rbfox3 enhanced tau exon 10 inclusion. Tau intron 10 contains UGCAUG, the conservative binding sequence of Rbfox3. Intron 10 of tau pre-mRNA was co-immunoprecipitated …by Rbfox3/NeuN. Deletion mutants of the RNA recognition motif (RRM) or three RNA-binding sites of the RRM in Rbfox3/NeuN failed to enhance tau exon 10 inclusion. Rbfox3, specifically expressed in the fetal brain, did not affect tau exon 10 splicing. The level of Rbfox3/NeuN was reduced and was associated with the ratio of 4R-tau/3R-tau in the excitotoxic mouse brains induced by kainic acid. These findings suggest that Rbfox3/NeuN regulates the alternative splicing of tau exon 10 and that decreased Rbfox3/NeuN may lower the ratio of 4R-tau/3R-tau. Show more
Keywords: Alternative splicing, alzheimer’s disease, rbfox3/NeuN, tau
DOI: 10.3233/JAD-180882
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1695-1704, 2018
Authors: Goto, Seiko | Shen, Xuting | Sun, Minkai | Hamano, Yutaka | Herrup, Karl
Article Type: Research Article
Abstract: Dementia is highly prevalent among the worldwide elderly population. Only a small number of the currently marketed drugs are effective in controlling its symptoms, and none has any effect on its progression. Further, as the condition advances, even these pharmaceuticals lose their efficiency, and new research into interventions that might improve the life quality of patients at the end stage of dementia and their families is increasingly rare. In our previous studies, we explored the benefits of exposure to nature, in the form of a Japanese garden, for persons with advanced dementia. In the current work, we extended our observations …to two new locations and a new set of subjects with a different ethnic composition with the goal of identifying interventions that might improve their quality of life. We found that, even in these new settings, garden observation not only relieved physiological stress, it improved qualitative measures such as verbalization and memory retrieval. We present data that viewing the garden is a holistic experience rather a solely visual stimulus. Our new data further support the conclusion that garden observation is worth including in the care planning schedule of advanced dementia patients. Its low cost and easy availability make it an economical adjunct to current pharmacological methods that has the potential to improve the quality of life of people with dementia. Show more
Keywords: Dementia, heart rate, Japanese garden, memory retrieval, stress relief
DOI: 10.3233/JAD-170510
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1705-1720, 2018
Authors: Choi, Hojin | Yang, YoungSoon | Han, Hyun Jeong | Jeong, Jee Hyang | Park, Mee Young | Kim, Yong Bum | Jo, Kwang Deog | Choi, Jin-Yong | Kang, Kyung-Hun | Kang, Heeyoung | Kwon, Do-Young | Yoo, Bong-Goo | Lee, Hyun Jin | Shin, Byoung-Soo | Jeon, Sung-Man | Kwon, Oh Dae | Kim, Jin-Suk | Lee, Soo-Joo | Kim, Youngsoo | Park, Tai-Hwan | Kim, Young Jin | Yang, Hui-Jun | Park, Hyun-Young | Shin, Hae-Eun | Lee, Jung Seok | Jung, Yo Han | Lee, Ae Young | Shin, Dong-Ick | Shin, Kyong Jin | Park, Kee Hyung
Article Type: Research Article
Abstract: Background: Magnetic resonance imaging (MRI) is a useful tool to predict the diagnosis and progression of Alzheimer’s disease (AD), especially for primary physicians. However, the correlation between baseline MRI findings and AD progression has not been fully established. Objective: To investigate the correlation between hippocampal atrophy (HA) and white matter hyperintensities (WMH) on initial brain MRI images and the degree of cognitive decline and functional changes over 1 year. Methods: In this prospective, 12-month observational study, dementia outpatients were recruited from 29 centers across South Korea. Baseline assessments of HA and WMH on baseline brain MRI …were derived as well as cognitive function, dementia severity, activities of daily living, and acetylcholinesterase inhibitor (AChEI) use. Follow-up assessments were conducted at 6 and 12 months. Results: Among 899 enrolled dementia patients, 748 were diagnosed with AD of whom 654 (87%) were taking AChEIs. Baseline WMH showed significant correlations with age, current alcohol consumption, and Clinical Dementia Rating score; baseline HA was correlated with age, family history, physical exercise, and the results of cognitive assessments. Among the AChEI group, changes in the Korean version of the Instrumental Activities of Daily Living (K-IADL) were correlated with the severity of HA on baseline brain MRI, but not with the baseline severity of WMH. In the no AChEI group, changes in K-IADL were correlated with the severity of WMH and HA at baseline. Conclusion: Baseline MRI findings could be a useful tool for predicting future clinical outcomes by primary physicians, especially in relation to patients’ functional status. Show more
Keywords: Atrophy, brain imaging, cognitive function, hippocampus, white matter hyperintensities
DOI: 10.3233/JAD-180565
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1721-1730, 2018
Authors: Fan, ShuJuan | Xian, XiaoHui | Li, Li | Yao, XiaoGuang | Hu, YuYan | Zhang, Min | Li, WenBin
Article Type: Research Article
Abstract: Alzheimer’s disease (AD) is characterized by progressive impairment of learning, memory, and cognitive deficits. Glutamate is the major excitatory neurotransmitter in the central nervous system and plays an important role in learning, memory, and cognition. The homeostasis and reutilization of glutamate are dependent on astrocytic uptake by glutamate transporter-1 (GLT-1) and the subsequent glutamate-glutamine cycle. Increasing evidence showed impairments in GLT-1 expression and uptake activity and glutamate-glutamine cycle in AD. Ceftriaxone (Cef) has been reported to upregulate the expression and uptake of GLT-1. Therefore, the present study was undertaken to explore whether Cef can improve cognitive deficits of APP/PS1 mice …in early stage of AD by upregulating GLT-1 expression, and then promoting the glutamate-glutamine cycle. It was shown that Cef treatment significantly alleviated the cognitive deficits measured by Morris water maze test and upregulated GLT-1 protein expression in the hippocampus of APP/PS1 mice. Particularly, the activity of glutamine synthetase (GS) and the protein expression of system N glutamine transporter 1 (SN1), which are the key factors involved in the glutamate-glutamine cycle, were significantly upregulated as well after the Cef treatment. Furthermore, inhibition of GLT-1 uptake activity by dihydrokainic acid, an inhibitor of GLT-1, blocked the Cef-induced improvement on the cognitive deficits, GS activity, and SN1 expression. The above results suggested that Cef could improve cognitive deficits of APP/PS1 mice in early stage of AD by upregulating the GLT-1 expression, GS activity, and SN1 expression, which would lead to stimulating the glutamate-glutamine cycle. Show more
Keywords: APP/PS1 mice, ceftriaxone, DHK, GLT-1, glutamate-glutamine cycle
DOI: 10.3233/JAD-180708
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1731-1743, 2018
Authors: Lahme, Larissa | Esser, Eliane Luisa | Mihailovic, Natasa | Schubert, Friederike | Lauermann, Jost | Johnen, Andreas | Eter, Nicole | Duning, Thomas | Alnawaiseh, Maged
Article Type: Research Article
Abstract: Background: There is increasing evidence for the involvement of cerebrovascular factors in Alzheimer’s disease (AD). Objective: To evaluate retinal and optic nerve head perfusion in patients with AD using optical coherence tomography angiography (OCTA), and to analyze the correlations of quantitative OCTA metrics with AD pathology and vascular cerebral lesions in AD patients. Methods: 36 eyes of 36 patients with AD (study group) and 38 eyes of 38 healthy subjects (control group) were prospectively included in this study. OCTA was performed using RTVue XR Avanti with AngioVue. In addition, patients underwent a detailed ophthalmological and neurological …examination including Mini-Mental State Examination, cerebral magnetic resonance imaging, and amyloid-β (Aβ) and tau levels in the cerebrospinal fluid (CSF). Results: The flow density in the superficial retinal OCT angiogram of the macula in the study group was significantly lower compared to the control group (p = 0.001). There was a significant correlation between the flow density in the superficial retinal OCT angiogram of the macula, as measured using OCTA, and the Fazekas scale (Spearman’s correlation coefficient = –0.520; p = 0.003). There was no significant correlation between the Aβ or tau levels in the CSF and the flow density data. Conclusion: Patients with AD showed a reduced flow density in the radial peripapillary capillaries layer and in the superficial retinal OCT angiogram when compared with healthy controls. The reduced retinal flow density measured using OCTA is not specifically associated with AD pathology but is associated with the vascular cerebral lesions in AD. Show more
Keywords: Alzheimer’s disease, flow density, optical coherence tomography angiography, retinal and optic nerve head perfusion
DOI: 10.3233/JAD-180738
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1745-1752, 2018
Authors: Javanshiri, Keivan | Waldö, Maria Landqvist | Friberg, Niklas | Sjövall, Fredrik | Wickerström, Karin | Haglund, Mattias | Englund, Elisabet
Article Type: Correction
DOI: 10.3233/JAD-189011
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1753-1753, 2018
Article Type: Other
DOI: 10.3233/JAD-189012
Citation: Journal of Alzheimer's Disease, vol. 66, no. 4, pp. 1755-1768, 2018
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl